Reaction #95606
ord-ab602c976b4e4ba7b37ddb85c0d566f3
Reaction equation
Reactants
Reagents
Solvents
Conditions
Workup
- 1OtherThe mixture is evaporated in vacuo
- 2Temperatureheated
- 3Temperatureunder reflux for 22 hours
- 4OtherAfter evaporation in vacuo
- 5workup.ADDITIONthe residue is treated with water
- 6Extractionextracted three times with 30 ml of chloroform each time
- 7WashThe combined chloroform phases are washed three times with 20 ml of water each time
- 8Dryingdried over magnesium sulphate
- 9Otherevaporated
- 10OtherAfter recrystallisation from ethyl acetate/n-hexane
Procedure
934 mg (3 mmol) of ethyl (S)-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate are stirred at 60° C. for 48 hours with 198 mg (3 mmol) of potassium cyanide in 30 ml of dry 2-propanol. The mixture is evaporated in vacuo. The residue is treated with 30 ml of 2-propanol and 198 mg (3 mmol) of potassium cyanide and heated to boiling under reflux for 22 hours. After evaporation in vacuo, the residue is treated with water and extracted three times with 30 ml of chloroform each time. The combined chloroform phases are washed three times with 20 ml of water each time, dried over magnesium sulphate and evaporated. After recrystallisation from ethyl acetate/n-hexane, there is obtained isopropyl (S)-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate of melting point 207°-208° C.